Atherosclerosis
Volume 183, Issue 2 , Pages 244-250 , December 2005

Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer

  • A. Susanne M. Zadelaar

      Affiliations

    • Department of Cardiology, Leiden University Medical Center c/o TNO Prevention and Health, Gaubius Laboratory, Zernikedreef 9, P.O. Box 2215, 2301 CE Leiden, The Netherlands
    • TNO-PG/Gaubius Laboratory, Leiden, Zernikedreef 9, P.O. Box 2215, 2301 CE Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 71 5181396; fax: +31 71 5181904.
    • ,
  • Jan H. von der Thüsen

      Affiliations

    • Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden, The Netherlands
    • ,
  • Lianne S. M. Boesten

      Affiliations

    • Department of Cardiology, Leiden University Medical Center c/o TNO Prevention and Health, Gaubius Laboratory, Zernikedreef 9, P.O. Box 2215, 2301 CE Leiden, The Netherlands
    • TNO-PG/Gaubius Laboratory, Leiden, Zernikedreef 9, P.O. Box 2215, 2301 CE Leiden, The Netherlands
    • ,
  • Rob C. Hoeben

      Affiliations

    • Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Mark M. Kockx

      Affiliations

    • Department of Pathology, Middelheim Academic Hospital, Antwerp, Belgium
    • ,
  • Marjan A. Versnel

      Affiliations

    • Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Theo J.C. van Berkel

      Affiliations

    • Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden, The Netherlands
    • ,
  • Louis M. Havekes

      Affiliations

    • Department of Cardiology, Leiden University Medical Center c/o TNO Prevention and Health, Gaubius Laboratory, Zernikedreef 9, P.O. Box 2215, 2301 CE Leiden, The Netherlands
    • TNO-PG/Gaubius Laboratory, Leiden, Zernikedreef 9, P.O. Box 2215, 2301 CE Leiden, The Netherlands
    • ,
  • Erik A. L. Biessen

      Affiliations

    • Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden, The Netherlands
    • ,
  • Bart J.M. van Vlijmen

      Affiliations

    • Department of Cardiology, Leiden University Medical Center c/o TNO Prevention and Health, Gaubius Laboratory, Zernikedreef 9, P.O. Box 2215, 2301 CE Leiden, The Netherlands
    • TNO-PG/Gaubius Laboratory, Leiden, Zernikedreef 9, P.O. Box 2215, 2301 CE Leiden, The Netherlands

Received 15 December 2004 ,Revised 4 March 2005 ,Accepted 14 March 2005.

References 

  1. Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449–1456
  2. Bellgrau D, Duke RC. Apoptosis and CD95 ligand in immune privileged sites. Int. Rev. Immunol. 1999;18:547–562
  3. Cai W, Devaux B, Schaper W, Schaper J. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis. 1997;131:177–186
  4. Henderson EL, Geng YJ, Sukhova GK, et al. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation. 1999;99:96–104
  5. Kiener PA, Davis PM, Rankin BM, et al. Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J. Immunol. 1997;159:1594–1598
  6. Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 1997;17:2200–2208
  7. Sata M, Suhara T, Walsh K. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy. Arterioscler. Thromb. Vasc. Biol. 2000;20:309–316
  8. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703–2711
  9. Bennett M, Macdonald K, Chan SW, et al. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science. 1998;282:290–293
  10. Yao PM, Tabas I. Free cholesterol loading of macrophages induces apoptosis involving the fas pathway. J. Biol. Chem. 2000;275:23807–23813
  11. Boyle JJ, Bowyer DE, Weissberg PL, Bennett MR. Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions. Arterioscler. Thromb. Vasc. Biol. 2001;21:1402–1407
  12. Luo Z, Sata M, Nguyen T, et al. Adenovirus-mediated delivery of fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals. Circulation. 1999;99:1776–1779
  13. Sata M, Perlman H, Muruve DA, et al. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc. Natl. Acad. Sci. U.S.A. 1998;95:1213–1217
  14. Schneider DB, Vassalli G, Wen S, et al. Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation. Arterioscler. Thromb. Vasc. Biol. 2000;20:298–308
  15. der Thusen JH, van Berkel TJ, Biessen EA. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation. 2001;103:1164–1170
  16. Fallaux FJ, Bout A, van dV I, et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 1998;9:1909–1917
  17. der Thusen JH, van Vlijmen BJ, Hoeben RC, et al. Induction of atherosclerotic plaque rupture in apolipoprotein E−/− mice after adenovirus-mediated transfer of p53. Circulation. 2002;105:2064–2070
  18. Kockx MM. Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler. Thromb. Vasc. Biol. 1998;18:1519–1522
  19. Gavrieli Y, Sherman Y, Ben Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 1992;119:493–501
  20. Van Blokland SC, Helden-Meeuwsen CG, Wierenga-Wolf AF, et al. Apoptosis and apoptosis-related molecules in the submandibular gland of the nonobese diabetic mouse model for Sjogren's syndrome: limited role for apoptosis in the development of sialoadenitis. Lab. Invest. 2003;83:3–11
  21. Williams H, Johnson JL, Carson KG, Jackson CL. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 2002;22:788–792
  22. Yang J, Sato K, Aprahamian T, et al. Endothelial overexpression of fas ligand decreases atherosclerosis in apolipoprotein e-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2004;24:1466–1473
  23. Wang T, Dong C, Stevenson SC, et al. P.J. Overexpression of soluble fas attenuates transplant arteriosclerosis in rat aortic allografts. Circulation. 2002;106:1536–1542
  24. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 1995;95:2266–2274
  25. Chan SW, Hegyi L, Scott S, et al. Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells. Circ. Res. 2000;86:1038–1046
  26. Burke B, Sumner S, Maitland N, Lewis CE. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. J. Leukoc. Biol. 2002;72:417–428
  27. Tran TH, Grey S, Anrather J, et al. Regulated and endothelial cell-specific expression of Fas ligand: an in vitro model for a strategy aiming at inhibiting xenograft rejection. Transplantation. 1998;66:1126–1131
  28. Sata M, Luo Z, Walsh K. Fas ligand overexpression on allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia. J. Immunol. 2001;166:6964–6971
  29. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 1994;94:2493–2503
  30. Galis ZS, Muszynski M, Sukhova GK, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 1994;75:181–189
  31. Schaub FJ, Han DK, Liles WC, et al. D.F. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat. Med. 2000;6:790–796
  32. Knapp AC, Huang J, Starling G, Kiener PA. Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death. Atherosclerosis. 2000;152:217–227

PII: S0021-9150(05)00214-5

doi: 10.1016/j.atherosclerosis.2005.03.044

Atherosclerosis
Volume 183, Issue 2 , Pages 244-250 , December 2005

Article Tools

* Image Usage & Resolution